Vanda Pharmaceuticals · 1 day ago
Associate/Sr. Associate, Government Affairs
Vanda Pharmaceuticals is a specialty pharmaceutical company focused on developing novel therapies to meet high unmet medical needs. They are seeking a talented individual to engage with legislative bodies and government agencies to represent and protect the organization’s interests.
BiopharmaBiotechnologyHealth Care
Responsibilities
Researches and monitors government activities that could affect the organization’s business and clients
Drafts and edits related correspondence
Coordinates and supports the logistics of meetings/engagements
Assists senior management and leadership with strategic planning for known and potential regulatory activities related to the business and industry
Builds and maintains professional relationships with members of federal, state, and local government entities and agencies
Collaborates with industry advocates to build areas of common interest
Introduces legislative and public policy changes that will support company operations
Performs other duties as required
Qualification
Required
Undergraduate or graduate degree in Business Administration, Political Science, Public Relations, or related field required
2+ years of experience in advocacy or public policy required
Excellent verbal and written communication skills
Self-motivated; ability to adapt within a dynamic environment
Excellent interpersonal and negotiation skills
Strong analytical and problem-solving skills
Proficient with Microsoft Office Suite or related software
Ability to multitask, work independently, and set own priorities, while maintaining accuracy and attention to details
Preferred
Strong government contacts at local, state, and federal levels are desirable but not required
Benefits
Health insurance
Unlimited paid time off
Parental leave
A 401k matching program
Other benefits
Company
Vanda Pharmaceuticals
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies.
Funding
Current Stage
Public CompanyTotal Funding
$72.5M2014-10-29Post Ipo Equity· $54M
2006-04-12IPO
2004-10-01Series B· $18.5M
Leadership Team
Recent News
2026-01-05
2026-01-03
MarketScreener
2026-01-03
Company data provided by crunchbase